Covestor Ltd - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$30
+172.7%
797
+564.2%
0.02%
+187.5%
Q2 2023$110.0%120
-29.0%
0.01%
-20.0%
Q1 2023$11
-38.9%
169
-50.0%
0.01%
+42.9%
Q4 2022$18
-99.8%
338
+91.0%
0.01%
-36.4%
Q3 2022$12,0000.0%177
-35.6%
0.01%
+10.0%
Q2 2022$12,000
-14.3%
275
-0.4%
0.01%
+11.1%
Q1 2022$14,000
+1300.0%
276
+1352.6%
0.01%
+800.0%
Q4 2021$1,000190.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
venBio Partners LLC 1,526,122$29,759,00024.10%
Cormorant Asset Management, LP 3,600,000$70,200,0004.74%
SECTORAL ASSET MANAGEMENT INC 1,727,829$33,693,0004.05%
Hillhouse Capital Management 2,098,581$40,922,0001.71%
HHLR ADVISORS, LTD. 2,579,708$50,304,0001.40%
CLOUGH CAPITAL PARTNERS L P 589,734$11,500,0001.01%
Vivo Capital, LLC 383,538$7,479,0000.75%
Opaleye Management Inc. 115,000$2,243,0000.62%
Virtus ETF Advisers LLC 14,338$280,0000.60%
Eversept Partners, LP 104,349$2,034,8060.59%
View complete list of APELLIS PHARMACEUTICALS INC shareholders